Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia. (2008)

First Author: Armitage J
Attributed to:  Large Randomised Lipid Modification Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/hrt.2007.137380

PubMed Identifier: 18411355

Publication URI: http://europepmc.org/abstract/MED/18411355

Type: Journal Article/Review

Volume: 94

Parent Publication: Heart (British Cardiac Society)

Issue: 5

ISSN: 1355-6037